<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Cytogenetic studies were performed on a group of 32 patients with <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>Five patients had <z:hpo ids='HP_0005505'>refractory anemia</z:hpo> (RA), four RA with ring sideroblasts (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RARS</z:e>), nine RA with excess blasts (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e>), eight <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e> 'in transformation' (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB-T</z:e>), three <z:hpo ids='HP_0011010'>chronic</z:hpo> myelomonocytic <z:hpo ids='HP_0001909'>leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CMML</z:e>) and three <z:e sem="disease" ids="C0280745" disease_type="Neoplastic Process" abbrv="">secondary MDS</z:e> (SMDS) </plain></SENT>
<SENT sid="2" pm="."><plain>Two patients in the SMDS group had been treated with <z:chebi fb="0" ids="22333">alkylating agents</z:chebi> for <z:e sem="disease" ids="C0242379" disease_type="Neoplastic Process" abbrv="">lung cancer</z:e> and <z:hpo ids='HP_0001901'>polycythemia</z:hpo> vera, respectively </plain></SENT>
<SENT sid="3" pm="."><plain>The other had been exposed to thorotrast </plain></SENT>
<SENT sid="4" pm="."><plain>Chromosome analyses were performed with Q and G bandings on bone marrow cells incubated for 24 hr </plain></SENT>
<SENT sid="5" pm="."><plain>A clonal chromosomal abnormality was observed in the marrow cells from 19 of the 32 patients (59%) </plain></SENT>
<SENT sid="6" pm="."><plain>Chromosomal abnormalities of nos </plain></SENT>
<SENT sid="7" pm="."><plain>5 and/or 7 were found in five patients, and were probably specific for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB-T</z:e> and SMDS </plain></SENT>
<SENT sid="8" pm="."><plain>Among the twelve patients with solely abnormal metaphases (AA), eight (67%) progressed to <z:hpo ids='HP_0002488'>acute leukemia</z:hpo>, a higher proportion than the three from the 13 patients (23%) with solely <z:mpath ids='MPATH_458'>normal</z:mpath> metaphases (NN) (P less than 0.05) </plain></SENT>
<SENT sid="9" pm="."><plain>One of the seven patients (14%) with both <z:mpath ids='MPATH_458'>normal</z:mpath> and abnormal metaphases (AN) developed <z:hpo ids='HP_0002488'>acute leukemia</z:hpo> (AA v </plain></SENT>
<SENT sid="10" pm="."><plain>AN, P less than 0.03) </plain></SENT>
<SENT sid="11" pm="."><plain>In only two of the 12 patients who progressed to <z:hpo ids='HP_0002488'>acute leukemia</z:hpo> (17%), was complete remission achieved </plain></SENT>
<SENT sid="12" pm="."><plain>The median survival time was only 4.0 months for patients with karyotype AA compared with 18.0 months for AN and 24.0 months for NN (AA v </plain></SENT>
<SENT sid="13" pm="."><plain>AN, P less than 0.05, AA v </plain></SENT>
<SENT sid="14" pm="."><plain>NN, P less than 0.05) </plain></SENT>
<SENT sid="15" pm="."><plain>The absence of cytogenetically <z:mpath ids='MPATH_458'>normal</z:mpath> cells indicated a poor prognosis with frequent progression to <z:hpo ids='HP_0002488'>acute leukemia</z:hpo> which is resistant to chemotherapy </plain></SENT>
<SENT sid="16" pm="."><plain>Progression to <z:hpo ids='HP_0002488'>acute leukemia</z:hpo> depended not only on chromosomal abnormalities but also on morphological subtype classified according to French-American-British co-operative group criteria </plain></SENT>
<SENT sid="17" pm="."><plain>Morphological findings and karyotype combined gave a good indication of the outcome for patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> </plain></SENT>
</text></document>